Company Overview and News

1
CareTrust REIT Announces Quarterly Dividend of $0.205 per Share

2018-06-18 globenewswire
SAN CLEMENTE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that its Board of Directors has declared a quarterly common stock cash dividend of $0.205 per common share. The current quarterly dividend is payable to common stockholders of record as of the close of business on June 29, 2018. The Company intends to pay the dividend on or about July 13, 2018.
CTRE

60
REIT Week Edition: My Top 10 Dividend Growers

2018-06-06 seekingalpha
I’m on the road (again) - this time in New York City, interviewing CEOs and shaking lots of hands at the preeminent commercial real estate investor conference, REITweek, hosted by the industry’s association NAREIT. Amidst the continental power breakfasts and lunch spreads, I thought I’d quickly serve up what’s cooking among the most prominent dividend growers in the Real Estate “kitchen.”
APTS EQIX COR.PRACL AMT.PRB AMT.PRA COR.PRA UMH.PRD CTRE UMH.PRC CONE UMH.PRB UMH.PRA FRT AMT COR GTY UMH

1
CTRE / CareTrust REIT, Inc. 8-K (Current Report)

2018-05-31 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CTRE

2
3 Pros, 3 Cons of Investing in the Best REITs for Income

2018-05-12 investorplace
Since their creation in 1960, real estate investment trusts (REITs) have become an increasingly popular investment, and investors frequently seek the best REITs for income. REITs are companies whose assets consist mainly of real estate holdings. They also receive more favorable tax treatment. In exchange, they must distribute at least 90% of their income to unitholders.
CTRE PLD WSR DLR

1
CareTrust REIT's (CTRE) CEO Gregory Stapley on Q1 2018 Results - Earnings Call Transcript

2018-05-09 seekingalpha
Welcome to CareTrust REIT's Q1 2018 Earnings Call. Please note that this call is being recorded. Before we begin please be advised that any forward-looking statements made on today's call are based on management's current expectations, assumptions and beliefs about CareTrust REIT’s business and the environment in which it operates.
CTRE

1
CareTrust REIT 2018 Q1 - Results - Earnings Call Slides

2018-05-09 seekingalpha
The following slide deck was published by CareTrust REIT in conjunction with their 2018 Q1 earnings call.
CTRE

1
CTRE / CareTrust REIT, Inc. 10-Q (Quarterly Report)

2018-05-08 sec.gov
Document Table of Contents
CTRE

2
The Ensign Group's (ENSG) CEO Christopher Christensen on Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
The Ensign Group, Inc. (NASDAQ:ENSG) Q1 2018 Earnings Conference Call May 3, 2018 1:00 PM ET
CTRE ENSG

1
CareTrust REIT Schedules First Quarter Earnings Call for Wednesday, May 9, 2018

2018-05-03 globenewswire
SAN CLEMENTE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its first quarter 2018 financial results after the market closes on Tuesday, May 8, 2018. Representatives of CareTrust REIT's management team will host a conference call to discuss the results the following day.
CTRE

1
CareTrust REIT Credit Ratings Upgraded by S&P Global Ratings

2018-04-24 globenewswire
SAN CLEMENTE, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it received upgraded credit ratings from Standard & Poor’s.
CTRE

14
Sabra: A Healthcare REIT With Tailwinds And A 10.5% Dividend

2018-04-23 seekingalpha
Sabra Healthcare Inc. (SBRA) has had its stock price beaten down along with other healthcare real estate companies over the last four months. Many investors do not want to bother with such a laggard. For those up to the challenge, here is a look under the hood.
CTRE LTC GEN CCP NHI

1
CTRE / CareTrust REIT, Inc. DEFA14A

2018-04-20 sec.gov
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CTRE

1
CTRE / CareTrust REIT, Inc. DEF 14A

2018-04-20 sec.gov
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
CTRE

1
CTRE / CareTrust REIT, Inc. PRE 14A

2018-04-06 sec.gov
PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2
CTRE

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to CTRE / CareTrust REIT, Inc. on message board site Silicon Investor.

Which film actress would you most like to sleep with? ASCTrend (by AbleSys Corp)
CUSIP: 14174T107